MarkWatsonMD

Emergency Medicine • New Hyde Park, NY

Medical Director

Join to view full profile

Dr. Watson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Watson's full profile

Already have an account?

Office
270-05 76th Avenue
New Hyde Park, NY 11040
Phone+1 718-470-7501

Fax+1 718-470-9113

Education & Training

Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine/Emergency Medicine, 1996 - 2001
State University of New York Downstate Medical Center College of MedicineClass of 1996

Certifications & Licensure

NY State Medical License 1998 - 2025
NJ State Medical License 2001 - 2023
MN State Medical License 2016 - 2022
MT State Medical License 2016 - 2022
American Board of Emergency Medicine Emergency Medicine

Publications & Presentations

PubMed

182 citations
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors.
Mark F. Watson, Anne Roulston, Laurent Bélec, Xavier Billot, Richard C. Marcellus
Molecular and Cellular Biology. 2009-11-01

Press Mentions

Guardian Research Network® Forms Scientific Advisory Council to Ensure Real World Data Continues to Positively Impact Clinical ResearchJuly 5th, 2022
Mercury Exposure in Songbird Communities Along an Elevational Gradient on Whiteface Mountain, Adirondack Park (New York, USA)March 30th, 2020
After Obesity Surgery, More Patients Returning for AnotherFebruary 28th, 2020
Join now to see all